937 related articles for article (PubMed ID: 27866691)
1. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
2. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
3. Perceptual structure of adductor spasmodic dysphonia and its acoustic correlates.
Cannito MP; Doiuchi M; Murry T; Woodson GE
J Voice; 2012 Nov; 26(6):818.e5-13. PubMed ID: 23177751
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
Morzaria S; Damrose EJ
J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
[TBL] [Abstract][Full Text] [Related]
6. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.
Braden MN; Johns MM; Klein AM; Delgaudio JM; Gilman M; Hapner ER
J Voice; 2010 Mar; 24(2):242-9. PubMed ID: 19481417
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of Persian Version of Consensus Auditory Perceptual Evaluation of Voice (CAPE-V), Persian Version of Voice Handicap Index (VHI), and Praat in Vocal Mass Lesions with Muscle Tension Dysphonia.
Khoramshahi H; Khatoonabadi AR; Khoddami SM; Dabirmoghaddam P; Ansari NN
J Voice; 2018 Nov; 32(6):770.e21-770.e30. PubMed ID: 29029830
[TBL] [Abstract][Full Text] [Related]
8. Voice Self-assessment Protocols: Different Trends Among Organic and Behavioral Dysphonias.
Behlau M; Zambon F; Moreti F; Oliveira G; de Barros Couto E
J Voice; 2017 Jan; 31(1):112.e13-112.e27. PubMed ID: 27210475
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life and Voice Changes After a Single Injection in Patients With ADSD Over Time.
Faham M; Torabinezhad F; Murry T; Dabirmoghaddam P; Abolghasemi J; Kamali M; Asgari M
J Voice; 2019 Sep; 33(5):721-727. PubMed ID: 29884509
[TBL] [Abstract][Full Text] [Related]
10. Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin.
Esposito M; Dubbioso R; Apisa P; Allocca R; Santoro L; Cesari U
Neurol Sci; 2015 Sep; 36(9):1679-82. PubMed ID: 25966878
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
12. Refractory Dysphonia Due to Isolated Cricothyroid Muscle Dystonia.
Kraft S; Childes J; Hillel A; Schindler J
J Voice; 2016 Jul; 30(4):501-5. PubMed ID: 26239970
[TBL] [Abstract][Full Text] [Related]
13. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
[TBL] [Abstract][Full Text] [Related]
14. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
[TBL] [Abstract][Full Text] [Related]
15. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
Cha W; Jang JY; Wang SG; Kang JH; Jo MG
J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
[TBL] [Abstract][Full Text] [Related]
16. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
Meyer TK; Hu A; Hillel AD
Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Occupation on Self-perceived Vocal Problems in Patients With Voice Complaints.
Ebersole B; Soni RS; Moran K; Lango M; Devarajan K; Jamal N
J Voice; 2018 Nov; 32(6):673-680. PubMed ID: 28967587
[TBL] [Abstract][Full Text] [Related]
18. Spasmodic dysphonia: let's look at that again.
Murry T
J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
[TBL] [Abstract][Full Text] [Related]
19. A Measure of the Auditory-perceptual Quality of Strain from Electroglottographic Analysis of Continuous Dysphonic Speech: Application to Adductor Spasmodic Dysphonia.
Somanath K; Mau T
J Voice; 2016 Nov; 30(6):770.e9-770.e21. PubMed ID: 26739857
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic Variables of Patients with Spasmodic Dysphonia: A Preliminary Study.
O'Connell Ferster AP; Sataloff RT; Shewokis PA; Hu A
J Voice; 2018 Jul; 32(4):479-483. PubMed ID: 28927659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
